
JSH-23
CAS No. 749886-87-1
JSH-23 ( NF-κB Activation Inhibitor II )
产品货号. M15858 CAS No. 749886-87-1
JSH-23 是 NF-κB 转录活性的抑制剂,IC50 为 7.1 μM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥421 | 有现货 |
![]() ![]() |
5MG | ¥689 | 有现货 |
![]() ![]() |
10MG | ¥988 | 有现货 |
![]() ![]() |
25MG | ¥1596 | 有现货 |
![]() ![]() |
50MG | ¥2406 | 有现货 |
![]() ![]() |
100MG | ¥3669 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称JSH-23
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述JSH-23 是 NF-κB 转录活性的抑制剂,IC50 为 7.1 μM。
-
产品描述JSH-23 is an inhibitor of NF-κB transcriptional activity with IC50 of 7.1 μM.(In Vitro):JSH-2 (1-300 μM; 24 hours) at <100 μM does not show significant cytotoxic effects on the RAW 264.7 cells.Nuclear amount of NF-κB p65 is markedly increased upon exposure to LPS for 1 h. Treatment of JSH-23 (30 μM; 1 hours) to LPS- stimulated RAW 264.7 cells decreases nuclear content of NF-κB p65 in a dose-dependent manner.(In Vivo):JSH-23 (1 mg/kg, 3 mg/kg; orally administered; daily; for 2 weeks) significantly reverses the nerve conduction and nerve blood flow deficits seen in diabetic rats.
-
体外实验JSH-2 (1-300 μM; 24 hours) at <100 μM does not show significant cytotoxic effects on the RAW 264.7 cells.Nuclear amount of NF-κB p65 is markedly increased upon exposure to LPS for 1 h. Treatment of JSH-23 (30 μM; 1 hours) to LPS- stimulated RAW 264.7 cells decreases nuclear content of NF-κB p65 in a dose-dependent manner.Cell Cytotoxicity Assay Cell Line:Macrophages RAW 264.7 Concentration:1, 3, 10, 30, 100, 300 μM Incubation Time:24 hours Result:Did not show significant cytotoxic effects at <100 μM.Western Blot Analysis Cell Line:Macrophages RAW 264.7 with LPS-stimulated Concentration:30 μM Incubation Time:1 hour Result:Decreased nuclear content of NF-κB p65 in a dose-dependent manner, corresponding to 49±4% inhibition at 3 μM, 75±7% at 10 μM and 95±8% at 30 μM.
-
体内实验JSH-23 (1 mg/kg, 3 mg/kg; orally administered; daily; for 2 weeks) significantly reverses the nerve conduction and nerve blood flow deficits seen in diabetic rats. Animal Model:Male Sprague Dawley diabetic rats (250-270 g)Dosage:1 mg/kg, 3 mg/kg Administration:Orally administered; daily; for 2 weeks Result:Produced significant improvement in motor nerve conduction velocity (MNCV).
-
同义词NF-κB Activation Inhibitor II
-
通路Apoptosis
-
靶点NF-κB
-
受体NF-κB
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number749886-87-1
-
分子量240.34
-
分子式C16H20N2
-
纯度>98% (HPLC)
-
溶解度Ethanol: 20 mg/mL (83.21 mM); DMSO: 48 mg/mL (199.71 mM)
-
SMILESNC1=CC(C)=CC=C1NCCCC2=CC=CC=C2
-
化学全称4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Kasparkova J, et al. FEBS J. 2014, doi: 10.1111/febs.1271
产品手册




关联产品
-
Gue1654
Gue1654 是 OXE-R 的调节剂。Gue1654 抑制 Gβγ 但不抑制 Gα 信号传导,该信号由化学引诱受体 OXE-R 激活 Gα(i)-βγ 触发。Gue1654 不会直接干扰 Gβγ 处或下游的信号传导。
-
SR12343
SR12343 (SR-12343) 是一种新型 NF-κB 必需调节剂 (NEMO) 结合域 (NBD) 模拟物,用于抑制 IKK/NF-κB 激活。
-
Isoliquiritin apiosi...
从甘草根茎中分离出的异甘草苷 apioside 可显着降低 PMA 诱导的 MMP9 活性增加,并抑制 PMA 诱导的 MAPK 和 NF-κB 激活。